Profile
Well-located properties in the core San Francisco Bay Area that offer true value-add
opportunities which may include new development, rehab, repositioning and/or releasing.
(Or properties that are just good strong income producers that can be acquired at a truly
below market price. Not just below replacement cost - below current market.) A property
with existing leased or partially leased buildings with surplus land for additional
development is desirable.
Property Types
R&D, flex, industrial, life sciences, medical office, mixed use and office. Multi-tenant
preferred over single occupant.
Priority Markets
The Greater San Francisco Bay Area.
Preferred Deal Size
$5- $20 million, however smaller and larger acquisition opportunities of a unique nature
will be considered.
Quality
We'll be most enthusiastic about properties that will, once repositioned, hold tenancy in
soft markets by virtue of Class A location, Class A quality, and supply constraints in the
sub-market in which the property is located or other characteristics that make the property
a unique asset. Properties that can be upgraded to at least Class B in primary markets will
also be evaluated.
Occupancy
0-100%. Properties with partial occupancy or for whom a user has been identified will be
favored.
Environmental
Environmentally impaired properties will be considered.
Due Diligence/Closing
We can be responsive and move quickly but expect adequate time to be provided for a due
diligence period appropriate to the challenges and risks associated with the property.
Structure
Purchase of 100% fee simple interest preferred; joint venture structures will be considered
for an extraordinary opportunity.
Broker Relationship
The firm acts solely as a principal and does not participate in brokerage fees. We will
accept submittals from listing brokers only except in the case of off-market deals.
Chamberlin Associates will provide fee protection to brokers that bring off-market
transactions to the firm provided the property has not been present by another broker and is
not currently under consideration.
|